Invesco Biotechnology & Genome ETF (PBE)
$95.07
▼ -0.03 (-0.03%)
1-day change
$92.62 – $98.82
52-week range
+0.07%
Premium / Discount
Net flows (30d): +$1.9M Estimated from creation/redemption of shares outstanding
Top 10 holdings weight48.23%
Effective number of positions26.5
Positions above 1%30
Net assets
$423.5M
Holdings
33
As of
Sept. 30, 2026
PBE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -3.66% | ▼ -3.64% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -0.22% | ▼ -0.20% |
Volatility 1Y·
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jul 2026)
+$4.6M
Quarter ending Jul 2026
+$5.9M
Trailing 12 months
-$16.8M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 33 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| Natera Inc | NTRA | 6.29 | ≈$26.6M | 63,892 | 632307104 | 0.01466 | EQUITY | USD |
| Illumina Inc | ILMN | 6.13 | ≈$25.9M | 95,618 | 452327109 | 0.02194 | EQUITY | USD |
| Biogen Inc | BIIB | 5.23 | ≈$22.2M | 97,446 | 09062X103 | 0.02235 | EQUITY | USD |
| Gilead Sciences Inc | GILD | 5.14 | ≈$21.8M | 144,606 | 375558103 | 0.03317 | EQUITY | USD |
| Royalty Pharma PLC | RPRX | 4.82 | ≈$20.4M | 346,593 | G7709Q104 | 0.07951 | EQUITY | USD |
| Amgen Inc | AMGN | 4.78 | ≈$20.2M | 48,646 | 031162100 | 0.01116 | EQUITY | USD |
| Vertex Pharmaceuticals Inc | VRTX | 4.75 | ≈$20.1M | 38,913 | 92532F100 | 0.008927 | EQUITY | USD |
| Regeneron Pharmaceuticals Inc | REGN | 4.57 | ≈$19.4M | 25,808 | 75886F107 | 0.005922 | EQUITY | USD |
| Moderna Inc | MRNA | 3.37 | ≈$14.3M | 73,884 | 60770K107 | 0.01695 | EQUITY | USD |
| Novavax Inc | NVAX | 3.18 | ≈$13.5M | 1,243,050 | 670002401 | 0.2851 | EQUITY | USD |
| United Therapeutics Corp | UTHR | 3.12 | ≈$13.2M | 22,631 | 91307C102 | 0.005191 | EQUITY | USD |
| Exelixis Inc | EXEL | 2.89 | ≈$12.2M | 206,883 | 30161Q104 | 0.04746 | EQUITY | USD |
| Veracyte Inc | VCYT | 2.84 | ≈$12.0M | 266,448 | 92337F107 | 0.06112 | EQUITY | USD |
| Halozyme Therapeutics Inc | HALO | 2.77 | ≈$11.7M | 107,340 | 40637H109 | 0.02462 | EQUITY | USD |
| Repligen Corp | RGEN | 2.76 | ≈$11.7M | 64,585 | 759916109 | 0.01482 | EQUITY | USD |
| TG Therapeutics Inc | TGTX | 2.74 | ≈$11.6M | 211,736 | 88322Q108 | 0.04857 | EQUITY | USD |
| QIAGEN NV | QGEN | 2.72 | ≈$11.5M | 268,829 | N72482156 | 0.06167 | EQUITY | USD |
| Sarepta Therapeutics Inc | SRPT | 2.63 | ≈$11.1M | 620,211 | 803607100 | 0.1423 | EQUITY | USD |
| Protagonist Therapeutics Inc | PTGX | 2.62 | ≈$11.1M | 77,923 | 74366E102 | 0.01788 | EQUITY | USD |
| Neurocrine Biosciences Inc | NBIX | 2.60 | ≈$11.0M | 76,511 | 64125C109 | 0.01755 | EQUITY | USD |
| Vericel Corp | VCEL | 2.58 | ≈$10.9M | 271,504 | 92346J108 | 0.06228 | EQUITY | USD |
| Legend Biotech Corp | LEGN | 2.57 | ≈$10.9M | 550,910 | 52490G102 | 0.1264 | ADR | USD |
| Incyte Corp | INCY | 2.55 | ≈$10.8M | 90,459 | 45337C102 | 0.02075 | EQUITY | USD |
| Ardelyx Inc | ARDX | 2.53 | ≈$10.7M | 3,104,336 | 039697107 | 0.7121 | EQUITY | USD |
| BioMarin Pharmaceutical Inc | BMRN | 2.50 | ≈$10.6M | 177,471 | 09061G101 | 0.04071 | EQUITY | USD |
| PTC Therapeutics Inc | PTCT | 2.47 | ≈$10.5M | 159,717 | 69366J200 | 0.03664 | EQUITY | USD |
| AnaptysBio Inc | ANAB | 2.36 | ≈$10.0M | 201,034 | 032724106 | 0.04612 | EQUITY | USD |
| BioCryst Pharmaceuticals Inc | BCRX | 2.34 | ≈$9.9M | 1,193,733 | 09058V103 | 0.2738 | EQUITY | USD |
| Collegium Pharmaceutical Inc | COLL | 2.25 | ≈$9.5M | 427,171 | 19459J104 | 0.09799 | EQUITY | USD |
| ACADIA Pharmaceuticals Inc | ACAD | 1.84 | ≈$7.8M | 383,853 | 004225108 | 0.08805 | EQUITY | USD |
| Invesco Government & Agency Portfolio | AGPXX | 0.08 | ≈$349K | 342,045 | 825252885 | 0.07845 | OTHER | USD |
| CASH & EQUIVALENTS | USD | 0.00 | ≈$6K | 5,728 | CASHUSD00 | 0.001314 | CASH | USD |
| SECURITIES LENDING - BNYM | 0.00 | · | 1 | BNYMLEND | 0.0000002294 | OTHER | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Sector breakdown
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Sept. 29, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.05125 → 0.07845 (53.1%) |
| Sept. 25, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.06992 → 0.05125 (-26.7%) |
| Sept. 24, 2026 | Increased | USD — CASH & EQUIVALENTS | Units/share: 0.0004359 → 0.001314 (201.4%) |
| Sept. 23, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.0723 → 0.06992 (-3.3%) |
| Sept. 22, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.07142 → 0.0723 (1.2%) |
| Sept. 22, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.001314 → 0.0004359 (-66.8%) |
| Sept. 21, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.05656 → 0.07142 (26.3%) |
| Sept. 16, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.08918 → 0.05656 (-36.6%) |
| Sept. 16, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.004848 → 0.001314 (-72.9%) |
| Sept. 15, 2026 | Increased | USD — CASH & EQUIVALENTS | Units/share: 0.001314 → 0.004848 (269.0%) |
| Sept. 11, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.0603 → 0.08918 (47.9%) |
| Sept. 10, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.04366 → 0.0603 (38.1%) |
| Sept. 8, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.04397 → 0.04366 (-0.7%) |
| Sept. 8, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.00132 → 0.001314 (-0.5%) |
| Sept. 8, 2026 | Trimmed | — SECURITIES LENDING - BNYM | Units/share: 0.0000002304 → 0.0000002294 (-0.5%) |
| Sept. 4, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.04047 → 0.04397 (8.7%) |
| Sept. 3, 2026 | Trimmed | ACAD — ACADIA Pharmaceuticals Inc | Units/share: 0.08856 → 0.08805 (-0.6%) |
| Sept. 3, 2026 | New | AGPXX — Invesco Government & Agency Portfolio | New position — 0.04047 units/share |
| Sept. 3, 2026 | Trimmed | AMGN — Amgen Inc | Units/share: 0.01122 → 0.01116 (-0.6%) |
| Sept. 3, 2026 | Trimmed | ANAB — AnaptysBio Inc | Units/share: 0.04638 → 0.04612 (-0.6%) |
| Sept. 3, 2026 | Trimmed | ARDX — Ardelyx Inc | Units/share: 0.7162 → 0.7121 (-0.6%) |
| Sept. 3, 2026 | Trimmed | BCRX — BioCryst Pharmaceuticals Inc | Units/share: 0.2754 → 0.2738 (-0.6%) |
| Sept. 3, 2026 | Trimmed | BIIB — Biogen Inc | Units/share: 0.02248 → 0.02235 (-0.6%) |
| Sept. 3, 2026 | Trimmed | BMRN — BioMarin Pharmaceutical Inc | Units/share: 0.04094 → 0.04071 (-0.6%) |
| Sept. 3, 2026 | Exited | CDNA | Position exited — was 0.00001615 units/share |
| Sept. 3, 2026 | Trimmed | COLL — Collegium Pharmaceutical Inc | Units/share: 0.09855 → 0.09799 (-0.6%) |
| Sept. 3, 2026 | Trimmed | EXEL — Exelixis Inc | Units/share: 0.04773 → 0.04746 (-0.6%) |
| Sept. 3, 2026 | Trimmed | GILD — Gilead Sciences Inc | Units/share: 0.03336 → 0.03317 (-0.6%) |
| Sept. 3, 2026 | Trimmed | HALO — Halozyme Therapeutics Inc | Units/share: 0.02477 → 0.02462 (-0.6%) |
| Sept. 3, 2026 | Trimmed | ILMN — Illumina Inc | Units/share: 0.02206 → 0.02194 (-0.6%) |
| Sept. 3, 2026 | Trimmed | INCY — Incyte Corp | Units/share: 0.02088 → 0.02075 (-0.6%) |
| Sept. 3, 2026 | Trimmed | LEGN — Legend Biotech Corp | Units/share: 0.1271 → 0.1264 (-0.6%) |
| Sept. 3, 2026 | Trimmed | MRNA — Moderna Inc | Units/share: 0.01704 → 0.01695 (-0.6%) |
| Sept. 3, 2026 | Trimmed | NBIX — Neurocrine Biosciences Inc | Units/share: 0.01765 → 0.01755 (-0.6%) |
| Sept. 3, 2026 | Trimmed | NTRA — Natera Inc | Units/share: 0.01474 → 0.01466 (-0.6%) |
| Sept. 3, 2026 | Trimmed | NVAX — Novavax Inc | Units/share: 0.2868 → 0.2851 (-0.6%) |
| Sept. 3, 2026 | Exited | OMER | Position exited — was 0.00001544 units/share |
| Sept. 3, 2026 | Trimmed | PTCT — PTC Therapeutics Inc | Units/share: 0.03685 → 0.03664 (-0.6%) |
| Sept. 3, 2026 | Trimmed | PTGX — Protagonist Therapeutics Inc | Units/share: 0.01798 → 0.01788 (-0.6%) |
| Sept. 3, 2026 | Trimmed | QGEN — QIAGEN NV | Units/share: 0.06202 → 0.06167 (-0.6%) |
| Sept. 3, 2026 | Trimmed | REGN — Regeneron Pharmaceuticals Inc | Units/share: 0.00596 → 0.005922 (-0.6%) |
| Sept. 3, 2026 | Trimmed | RGEN — Repligen Corp | Units/share: 0.01491 → 0.01482 (-0.6%) |
| Sept. 3, 2026 | Trimmed | RPRX — Royalty Pharma PLC | Units/share: 0.07996 → 0.07951 (-0.6%) |
| Sept. 3, 2026 | Trimmed | SRPT — Sarepta Therapeutics Inc | Units/share: 0.1431 → 0.1423 (-0.6%) |
| Sept. 3, 2026 | Exited | TECH | Position exited — was 0.00000285 units/share |
| Sept. 3, 2026 | Trimmed | TGTX — TG Therapeutics Inc | Units/share: 0.04885 → 0.04857 (-0.6%) |
| Sept. 3, 2026 | Increased | USD — CASH & EQUIVALENTS | Units/share: -0.5354 → 0.00132 (-100.2%) |
| Sept. 3, 2026 | Trimmed | UTHR — United Therapeutics Corp | Units/share: 0.00523 → 0.005191 (-0.8%) |
| Sept. 3, 2026 | Trimmed | VCEL — Vericel Corp | Units/share: 0.06264 → 0.06228 (-0.6%) |
| Sept. 3, 2026 | Trimmed | VCYT — Veracyte Inc | Units/share: 0.06147 → 0.06112 (-0.6%) |
| Sept. 3, 2026 | Trimmed | VRTX — Vertex Pharmaceuticals Inc | Units/share: 0.008979 → 0.008927 (-0.6%) |
| Sept. 3, 2026 | Trimmed | — SECURITIES LENDING - BNYM | Units/share: 0.0000002375 → 0.0000002304 (-3.0%) |
| Sept. 2, 2026 | Trimmed | ACAD — ACADIA Pharmaceuticals Inc | Units/share: 0.1046 → 0.08856 (-15.3%) |
| Sept. 2, 2026 | Exited | AGPXX — Invesco Government & Agency Portfolio | Position exited — was 0.01864 units/share |
| Sept. 2, 2026 | Exited | ALNY | Position exited — was 0.0138 units/share |
| Sept. 2, 2026 | Trimmed | AMGN — Amgen Inc | Units/share: 0.01212 → 0.01122 (-7.4%) |
| Sept. 2, 2026 | Increased | ANAB — AnaptysBio Inc | Units/share: 0.03849 → 0.04638 (20.5%) |
| Sept. 2, 2026 | Increased | ARDX — Ardelyx Inc | Units/share: 0.3558 → 0.7162 (101.3%) |
| Sept. 2, 2026 | Increased | BCRX — BioCryst Pharmaceuticals Inc | Units/share: 0.2625 → 0.2754 (4.9%) |
| Sept. 2, 2026 | Increased | BIIB — Biogen Inc | Units/share: 0.02111 → 0.02248 (6.5%) |
| Sept. 2, 2026 | Trimmed | BMRN — BioMarin Pharmaceutical Inc | Units/share: 0.04205 → 0.04094 (-2.6%) |
| Sept. 2, 2026 | Trimmed | CDNA | Units/share: 0.1032 → 0.00001615 (-100.0%) |
| Sept. 2, 2026 | Increased | COLL — Collegium Pharmaceutical Inc | Units/share: 0.06583 → 0.09855 (49.7%) |
| Sept. 2, 2026 | Increased | EXEL — Exelixis Inc | Units/share: 0.04449 → 0.04773 (7.3%) |
| Sept. 2, 2026 | Increased | GILD — Gilead Sciences Inc | Units/share: 0.03048 → 0.03336 (9.4%) |
| Sept. 2, 2026 | Trimmed | HALO — Halozyme Therapeutics Inc | Units/share: 0.03236 → 0.02477 (-23.5%) |
| Sept. 2, 2026 | Increased | ILMN — Illumina Inc | Units/share: 0.01531 → 0.02206 (44.1%) |
| Sept. 2, 2026 | Trimmed | INCY — Incyte Corp | Units/share: 0.0229 → 0.02088 (-8.8%) |
| Sept. 2, 2026 | Increased | LEGN — Legend Biotech Corp | Units/share: 0.0753 → 0.1271 (68.8%) |
| Sept. 2, 2026 | New | MRNA — Moderna Inc | New position — 0.01704 units/share |
| Sept. 2, 2026 | Increased | NBIX — Neurocrine Biosciences Inc | Units/share: 0.01428 → 0.01765 (23.6%) |
| Sept. 2, 2026 | New | NTRA — Natera Inc | New position — 0.01474 units/share |
| Sept. 2, 2026 | New | NVAX — Novavax Inc | New position — 0.2868 units/share |
| Sept. 2, 2026 | Trimmed | OMER | Units/share: 0.1909 → 0.00001544 (-100.0%) |
| Sept. 2, 2026 | Increased | PTCT — PTC Therapeutics Inc | Units/share: 0.03287 → 0.03685 (12.1%) |
| Sept. 2, 2026 | Trimmed | PTGX — Protagonist Therapeutics Inc | Units/share: 0.02224 → 0.01798 (-19.2%) |
| Sept. 2, 2026 | Trimmed | QGEN — QIAGEN NV | Units/share: 0.06257 → 0.06202 (-0.9%) |
| Sept. 2, 2026 | Trimmed | REGN — Regeneron Pharmaceuticals Inc | Units/share: 0.006415 → 0.00596 (-7.1%) |
| Sept. 2, 2026 | Trimmed | RGEN — Repligen Corp | Units/share: 0.0193 → 0.01491 (-22.8%) |
| Sept. 2, 2026 | Increased | RPRX — Royalty Pharma PLC | Units/share: 0.07569 → 0.07996 (5.6%) |
| Sept. 2, 2026 | Increased | SRPT — Sarepta Therapeutics Inc | Units/share: 0.1334 → 0.1431 (7.3%) |
| Sept. 2, 2026 | Trimmed | TECH | Units/share: 0.04636 → 0.00000285 (-100.0%) |
| Sept. 2, 2026 | New | TGTX — TG Therapeutics Inc | New position — 0.04885 units/share |
| Sept. 2, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.001164 → -0.5354 (-46084.0%) |
| Sept. 2, 2026 | Trimmed | UTHR — United Therapeutics Corp | Units/share: 0.00703 → 0.00523 (-25.6%) |
| Sept. 2, 2026 | Trimmed | VCEL — Vericel Corp | Units/share: 0.06359 → 0.06264 (-1.5%) |
| Sept. 2, 2026 | Increased | VCYT — Veracyte Inc | Units/share: 0.0503 → 0.06147 (22.2%) |
| Sept. 2, 2026 | Trimmed | VRTX — Vertex Pharmaceuticals Inc | Units/share: 0.009362 → 0.008979 (-4.1%) |
| Sept. 2, 2026 | Increased | — SECURITIES LENDING - BNYM | Units/share: 0.0000002033 → 0.0000002375 (16.9%) |
| Sept. 1, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.01884 → 0.01864 (-1.1%) |
| Sept. 1, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.001176 → 0.001164 (-1.0%) |
| Sept. 1, 2026 | Trimmed | — SECURITIES LENDING - BNYM | Units/share: 0.0000002053 → 0.0000002033 (-1.0%) |
| Aug. 31, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.01622 → 0.01884 (16.2%) |
| Aug. 31, 2026 | Trimmed | AMGN — Amgen Inc | Units/share: 0.01213 → 0.01212 (-0.1%) |
| Aug. 31, 2026 | Trimmed | REGN — Regeneron Pharmaceuticals Inc | Units/share: 0.006423 → 0.006415 (-0.1%) |
| Aug. 31, 2026 | New | USD — CASH & EQUIVALENTS | New position — 0.001176 units/share |
| Aug. 31, 2026 | Trimmed | UTHR — United Therapeutics Corp | Units/share: 0.007039 → 0.00703 (-0.1%) |
| Aug. 31, 2026 | Trimmed | — SECURITIES LENDING - BNYM | Units/share: 0.0000002421 → 0.0000002053 (-15.2%) |
Dividends 22 payments
1.40%TTM yield
$1.33TTM payout / share
Quarterly
(est.)
| Ex-date | Amount / share |
|---|---|
| Sept. 21, 2026 | $0.0190 |
| June 22, 2026 | $0.8110 |
| March 23, 2026 | $0.0820 |
| Dec. 22, 2025 | $0.4200 |
| Sept. 22, 2025 | $0.2340 |
| June 23, 2025 | $0.1300 |
| March 24, 2025 | $0.0340 |
| June 24, 2024 | $0.0080 |
| March 18, 2024 | $0.0240 |
| June 20, 2023 | $0.0140 |
| March 23, 2020 | $0.0290 |
| Sept. 24, 2018 | $0.0020 |
| June 16, 2017 | $0.2150 |
| March 17, 2017 | $0.0560 |
| Dec. 16, 2016 | $0.1210 |
| Sept. 16, 2016 | $0.0280 |
| Dec. 18, 2015 | $0.3080 |
| Sept. 18, 2015 | $0.1370 |
| June 19, 2015 | $0.1230 |
| Sept. 19, 2014 | $0.0430 |
| June 20, 2014 | $0.2340 |
| Dec. 18, 2009 | $0.0760 |
Institutional owners (13F) 115 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY | $13,312,723 | 14.12% | 148,498 | Shares | June 30, 2026 |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | $9,354,171 | 9.92% | 104,341 | Shares | June 30, 2026 |
| LPL Financial LLC | $8,276,536 | 8.78% | 92,322 | Shares | June 30, 2026 |
| UBS Group AG | $6,104,828 | 6.47% | 68,097 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $5,135,928 | 5.45% | 57,290 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $4,526,000 | 4.80% | 50,488 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $3,456,678 | 3.67% | 38,558 | Shares | June 30, 2026 |
| Gerber Kawasaki Wealth & Investment Management | $2,838,878 | 3.01% | 31,666 | Shares | June 30, 2026 |
| Cetera Investment Advisers | $2,309,389 | 2.45% | 25,760 | Shares | June 30, 2026 |
| YHB Investment Advisors, Inc. | $2,074,110 | 2.20% | 23,136 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $1,994,671 | 2.12% | 22,250 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $1,812,516 | 1.92% | 20,218 | Shares | June 30, 2026 |
| Penobscot Investment Management Company, Inc. | $1,743,665 | 1.85% | 19,450 | Shares | June 30, 2026 |
| Massachusetts Wealth Management | $1,594,311 | 1.69% | 17,784 | Shares | June 30, 2026 |
| US BANCORP \DE\ | $1,479,202 | 1.57% | 16,500 | Shares | June 30, 2026 |
| NewEdge Wealth, LLC | $1,234,641 | 1.31% | 13,772 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,184,360 | 1.26% | 13,211 | Shares | June 30, 2026 |
| Abbot Financial Management, Inc. | $1,095,954 | 1.16% | 12,225 | Shares | June 30, 2026 |
| Mariner, LLC | $1,059,644 | 1.12% | 11,820 | Shares | June 30, 2026 |
| CreativeOne Wealth, LLC | $976,484 | 1.04% | 10,893 | Shares | June 30, 2026 |
| Rockefeller Capital Management L.P. | $956,868 | 1.01% | 10,673 | Shares | June 30, 2026 |
| BENJAMIN EDWARDS INC | $929,414 | 0.99% | 10,363 | Shares | June 30, 2026 |
| JONES FINANCIAL COMPANIES LLLP | $913,562 | 0.97% | 10,186 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $904,595 | 0.96% | 10,090 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $864,301 | 0.92% | 9,641 | Shares | June 30, 2026 |
| Newman Dignan & Sheerar, Inc. | $840,007 | 0.89% | 9,370 | Shares | June 30, 2026 |
| Farther Finance Advisors, LLC | $822,436 | 0.87% | 9,174 | Shares | June 30, 2026 |
| RFG Advisory, LLC | $762,910 | 0.81% | 8,510 | Shares | June 30, 2026 |
| One Capital Management, LLC | $737,482 | 0.78% | 9,314 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $723,733 | 0.77% | 8,073 | Shares | June 30, 2026 |
| INVESTMENT HOUSE LLC | $616,782 | 0.65% | 6,880 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $605,868 | 0.64% | 6,758 | Shares | June 30, 2026 |
| Kestra Advisory Services, LLC | $593,759 | 0.63% | 6,623 | Shares | June 30, 2026 |
| Archford Capital Strategies, LLC | $560,483 | 0.59% | 6,252 | Shares | June 30, 2026 |
| Dynamic Advisor Solutions LLC | $483,923 | 0.51% | 5,398 | Shares | June 30, 2026 |
| FLAGSHIP HARBOR ADVISORS, LLC | $457,207 | 0.48% | 5,100 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $448,153 | 0.48% | 4,999 | Shares | June 30, 2026 |
| AXXCESS WEALTH MANAGEMENT, LLC | $423,590 | 0.45% | 4,725 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $422,424 | 0.45% | 4,712 | Shares | June 30, 2026 |
| Hills Bank & Trust Co | $403,329 | 0.43% | 4,499 | Shares | June 30, 2026 |
| STIFEL FINANCIAL CORP | $389,634 | 0.41% | 4,346 | Shares | June 30, 2026 |
| Creative Planning | $384,996 | 0.41% | 4,295 | Shares | June 30, 2026 |
| Envision Financial Transparency, LLC | $371,245 | 0.39% | 4,488 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $360,746 | 0.38% | 4,024 | Shares | June 30, 2026 |
| Pacific Sun Financial Corp | $328,293 | 0.35% | 3,662 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $304,805 | 0.32% | 3,400 | Shares | June 30, 2026 |
| BEESE FULMER INVESTMENT MANAGEMENT, INC. | $291,358 | 0.31% | 3,250 | Shares | June 30, 2026 |
| Connecticut Capital Management Group, LLC | $288,488 | 0.31% | 3,218 | Shares | June 30, 2026 |
| Stratos Wealth Partners, LTD. | $285,979 | 0.30% | 3,190 | Shares | June 30, 2026 |
| BLAIR WILLIAM & CO/IL | $277,642 | 0.29% | 3,097 | Shares | June 30, 2026 |
| Baird Financial Group, Inc. | $268,946 | 0.29% | 3,000 | Shares | June 30, 2026 |
| MONETA GROUP INVESTMENT ADVISORS LLC | $263,746 | 0.28% | 2,942 | Shares | June 30, 2026 |
| Sowell Financial Services LLC | $262,939 | 0.28% | 2,933 | Shares | June 30, 2026 |
| CWM, LLC | $262,642 | 0.28% | 3,317 | Shares | March 31, 2026 |
| Krasney Financial LLC | $260,937 | 0.28% | 3,295 | Shares | March 31, 2026 |
| Joel Isaacson & Co., LLC | $253,257 | 0.27% | 2,825 | Shares | June 30, 2026 |
| Western Wealth Management, LLC | $252,167 | 0.27% | 2,813 | Shares | June 30, 2026 |
| Summit Financial, LLC | $249,006 | 0.26% | 2,778 | Shares | June 30, 2026 |
| Capital Market Strategies LLC | $232,491 | 0.25% | 3,627 | Shares | June 30, 2025 |
| MML INVESTORS SERVICES, LLC | $227,151 | 0.24% | 2,534 | Shares | June 30, 2026 |
| Wharton Business Group, LLC | $224,749 | 0.24% | 2,507 | Shares | June 30, 2026 |
| VestGen Advisors, LLC | $220,446 | 0.23% | 2,459 | Shares | June 30, 2026 |
| Dana Investment Advisors, Inc. | $215,157 | 0.23% | 2,400 | Shares | June 30, 2026 |
| PFG Advisors | $211,929 | 0.22% | 2,364 | Shares | June 30, 2026 |
| Strategic Blueprint, LLC | $208,371 | 0.22% | 2,324 | Shares | June 30, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $169,470 | 0.18% | 1,890 | Shares | June 30, 2026 |
| GLENMEDE TRUST CO NA | $166,746 | 0.18% | 1,860 | Shares | June 30, 2026 |
| GeoWealth Management, LLC | $159,955 | 0.17% | 1,784 | Shares | June 30, 2026 |
| Millstone Evans Group, LLC | $159,754 | 0.17% | 1,782 | Shares | June 30, 2026 |
| Glenmede Investment Management, LP | $129,958 | 0.14% | 1,860 | Shares | Sept. 30, 2025 |
| FMR LLC | $126,121 | 0.13% | 1,407 | Shares | June 30, 2026 |
| Allworth Financial LP | $114,661 | 0.12% | 1,279 | Shares | June 30, 2026 |
| WEBSTER BANK, N. A. | $109,820 | 0.12% | 1,225 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $105,427 | 0.11% | 1,176 | Shares | June 30, 2026 |
| Innovative Asset Advisors Group, LLC | $98,613 | 0.10% | 1,100 | Shares | June 30, 2026 |
| Global Retirement Partners, LLC | $94,131 | 0.10% | 1,050 | Shares | June 30, 2026 |
| IFG Advisory, LLC | $74,102 | 0.08% | 827 | Shares | June 30, 2026 |
| BlackRock, Inc. | $59,437 | 0.06% | 663 | Shares | June 30, 2026 |
| AE Wealth Management LLC | $58,989 | 0.06% | 658 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $58,540 | 0.06% | 653 | Shares | June 30, 2026 |
| NewEdge Advisors, LLC | $58,063 | 0.06% | 648 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $56,299 | 0.06% | 628 | Shares | June 30, 2026 |
| OAKWORTH CAPITAL, INC. | $54,775 | 0.06% | 611 | Shares | June 30, 2026 |
| HOLLENCREST CAPITAL MANAGEMENT | $46,292 | 0.05% | 516 | Shares | June 30, 2026 |
| JPMORGAN CHASE & CO | $45,663 | 0.05% | 508 | Shares | June 30, 2026 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | $42,314 | 0.04% | 472 | Shares | June 30, 2026 |
| FIFTH THIRD BANCORP | $41,238 | 0.04% | 460 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $35,859 | 0.04% | 400 | Shares | June 30, 2026 |
| CIBC Private Wealth Group LLC | $33,887 | 0.04% | 485 | Shares | Sept. 30, 2025 |
| Financial Perspectives, Inc | $31,377 | 0.03% | 350 | Shares | June 30, 2026 |
| COMERICA BANK | $31,053 | 0.03% | 378 | Shares | Dec. 31, 2025 |
| PNC Financial Services Group, Inc. | $29,356 | 0.03% | 327 | Shares | June 30, 2026 |
| Aptus Capital Advisors, LLC | $28,239 | 0.03% | 315 | Shares | June 30, 2026 |
| Promus Capital, LLC | $19,703 | 0.02% | 282 | Shares | Sept. 30, 2025 |
| SIGNATUREFD, LLC | $19,095 | 0.02% | 213 | Shares | June 30, 2026 |
| Financial Avengers, Inc. | $18,293 | 0.02% | 204 | Shares | June 30, 2026 |
| McIlrath & Eck, LLC | $16,232 | 0.02% | 205 | Shares | March 31, 2026 |
| ENTRUST FINANCIAL LLC | $13,448 | 0.01% | 150 | Shares | June 30, 2026 |
| HARBOR INVESTMENT ADVISORY, LLC | $13,447 | 0.01% | 150 | Shares | June 30, 2026 |
| NATIONAL BANK OF CANADA /FI/ | $12,540 | 0.01% | 140 | Shares | June 30, 2026 |